Sign inJoin waitlistJoin the waitlist

SF

Sarah Fineberg

Instructor/Lecturer · Yale-New Haven Hospital

Credentials: · · ·

History

Yale-New Haven Hospital
Present
Yale-New Haven Hospital
Present

Yale-New Haven Hospital
Psychiatry
Yale-New Haven Hospital
2010–2014
University of Iowa, Physiology and Biophysics
Yale School of Medicine
2006–2010
Oberlin College, Biology
1996–2000

Research

MicroRNAs potentiate neural development
Review · Neuron · 2009 · First of 3 authors · 297 citations
Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial
American Journal of Psychiatry · 2022 · 67 citations
Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis
Neuroscience · 2012 · 62 citations

John Krystal
5 papers
Eli Neustadter
4 papers · 2 as a resident
CL
Christopher Landry
3 papers
CP
Christopher Pittenger
3 papers
MS
Matthew Steinfeld
3 papers
RS
Rosa Shapiro-Thompson
3 papers
Sasha Deutsch-Link
3 papers
Ayana Jordan
2 papers
BZ
Brian Zaboski
2 papers
CS
Charles Schleifer
2 papers · 1 as a resident
Daniel Diaz
2 papers · 2 as a resident
Khushwant Dhaliwal
2 papers

Grants

Mindfulness-Based Neurofeedback to Augment DBT Psychotherapy for Adults with Borderline Personality Disorder (MIND-BPD)
National Institute of Mental Health · R61
Contact PI · $2.3M · Yale University
2024–2027
Modeling Learning Under Volatility in Borderline Personality Disorder
National Institute of Mental Health · K23
Contact PI · $958.5K · Yale University
2020–2025

Clinical trials

MDMA in Borderline Personality Disorder
Principal investigator · Recruiting · Phase 2
Yale University
2025–2026
Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder
Principal investigator · Recruiting · Phase 2
Yale University
2025–2026
Measuring the Impact of Real Time fMRI Neurofeedback in Borderline Personality Disorder
Principal investigator · Completed
Yale University
2020–2022
Ketamine in Borderline Personality Disorder
Principal investigator · Terminated · Phase 2
Yale University
2018–2022